MRC Clinical Trials Unit at UCL
Menu
  • Home
  • About
    • Our Structure
      Our People
      History
      Our Environmental Commitment
  • News
  • Our Research
    • Cancer
      REFINE Add-Aspirin STAMPEDE RAMPART STOPCAP M1 UKCTOCS Open Studies Past Studies
      Infections
      Studies by Research Area
      Neurodegenerative Diseases
      OCTOPUS ACORD collaboration
      Methodology
      Design Conduct Analysis Meta-analysis Software
      Other Research & Policy
      Data Sharing Publications Studies in other areas Briefing Papers Regulatory information, Toolkits & Templates Our podcast
  • Studies
    • All Studies
      Studies Search
  • Patients & Public
    • About Clinical Trials
      What is a clinical trial? What is a randomised clinical trial? What is an observational study? How do we make sure a trial is safe? How is a trial designed and run? What happens at the end of a trial?
      Taking Part in a Clinical Trial
      How can you take part in a trial? What questions should you ask before participating in a trial?
      Patient and Public Involvement
      About our PPI group Our PPI Strategy PPI Resources
  • Education & Capacity Building
    • Enhancing skills of trial teams we work with across the globe
      Improving the clinical trials ecosystem
      Postgraduate Taught Courses
      Postgraduate Research Training
      NIHR Associate Principal Investigator (PI) Scheme
  • Careers
    • Our Vacancies
      Meet Our People
      Our Benefits
  • Contact

Cancer:

Open Studies

Our unit have been conducting trials in cancer for over 20 years.

View list of Cancer studies.

 

A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer.

STAMPEDE2

Add-Aspirin

A phase III double-blind, placebo-controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours

ARCHERY

A prospective observational study of artificial intelligence based radiotherapy treatment planning for cervical, head and neck and prostate cancer

DADSPORT

Duration of androgen suppression with post-operative radiotherapy (DADSPORT): A meta-analysis of aggregate data

REFINE

REduced Frequency ImmuNE checkpoint inhibition in cancers

STOPCAP M1 Programme

Speeding up the evaluation of therapies for metastatic, hormone-sensitive prostate cancer

UKLWC

UKCTOCS Longitudinal Women’s Cohort

  1. Home
  2. Our Research
  3. Cancer
  4. Open Studies

Contact Us

MRC Clinical Trials Unit at UCL
90 High Holborn
London
WC1V 6LJ

Quick links

  • News
  • Contact
  • Glossary
  • Cookies
  • Privacy

Social pages

  • twitter
  • linkedin
  • vimeo
  • youtube
  • soundcloud
  • © 2023
  • Glossary
  • Sitemap
  • Accessibility
  • Cookies
  • Privacy
  • Page last updated: 31-May-2022 14:22